1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Pacira Acquires Flexion Therapeutics

M&A Deal Summary

Pacira Acquires Flexion Therapeutics

On October 11, 2021, Pacira acquired life science company Flexion Therapeutics

Acquisition Highlights
  • This is Pacira’s 2nd transaction in the Life Science sector.
  • This is Pacira’s 2nd transaction in the United States.
  • This is Pacira’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2021-10-11
Target Flexion Therapeutics
Sector Life Science
Buyer(s) Pacira
Deal Type Add-on Acquisition
Advisor(s) Lazard
Goldman Sachs (Financial)
Cooley (Legal)

Target

Flexion Therapeutics

Burlington, Massachusetts, United States
Flexion Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, local non-opioid therapies for the treatment of patients with musculoskeletal conditions, including osteoarthritis (OA), postsurgical pain and low back pain. Flexion Therapeutics is based in Burlington, Massachusetts.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Pacira

Tampa, Florida, United States
Category Company
Founded 2006
Sector Life Science
Employees788
Revenue 701M USD (2024)
DESCRIPTION

Pacira is a specialty pharmaceutical company dedicated to advancing and improving postsurgical outcomes for acute care practitioners and their patients. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management. Pacira was founded in 2006 and is based in Tampa, Florida.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2021 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-26 GQ Bio Therapeutics

Hamburg, Germany

GQ Bio is a privately held biopharmaceutical company with a novel, high-capacity, local-delivery platform that makes genetic medicines more efficient and enables the use of large and multiple gene constructs. GQ Bio Therapeutics was founded in 2012 and is based in Hamburg, Germany.

Buy -
Mergr

Solution for

Product

Company

Legal